These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 16843618)
1. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618 [TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. Hidaka N; Nagao T; Asoh A; Kondo Y; Nagao K Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma. Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858 [TBL] [Abstract][Full Text] [Related]
5. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors. Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081 [TBL] [Abstract][Full Text] [Related]
6. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma. Awaya H; Takeshima Y; Amatya VJ; Ishida H; Yamasaki M; Kohno N; Inai K Pathol Int; 2005 Jan; 55(1):14-8. PubMed ID: 15660698 [TBL] [Abstract][Full Text] [Related]
7. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma. Nair KS; Naidoo R; Chetty R Hum Pathol; 2006 Feb; 37(2):125-34. PubMed ID: 16426911 [TBL] [Abstract][Full Text] [Related]
8. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366 [TBL] [Abstract][Full Text] [Related]
9. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ; Zhou QH; Zhang SF; Liu LX Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [TBL] [Abstract][Full Text] [Related]
10. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. Liu J; Ikeguchi M; Nakamura S; Kaibara N J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114 [TBL] [Abstract][Full Text] [Related]
13. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor). Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205 [TBL] [Abstract][Full Text] [Related]
14. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
15. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Lim SC; Lee MS Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049 [TBL] [Abstract][Full Text] [Related]
16. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis]. Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728 [TBL] [Abstract][Full Text] [Related]
18. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer. Li YJ; Meng YX; Ji XR Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963 [TBL] [Abstract][Full Text] [Related]
19. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. Krishnadath KK; Tilanus HW; van Blankenstein M; Hop WC; Kremers ED; Dinjens WN; Bosman FT J Pathol; 1997 Jul; 182(3):331-8. PubMed ID: 9349237 [TBL] [Abstract][Full Text] [Related]
20. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]